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Abstract. 
 
The cytoplasmic domains of integrins are es-
sential for cell adhesion. We report identification of a 
novel protein, ICAP-1 (integrin cytoplasmic domain–
 
associated protein-1), which binds to the
 
 
 
b
 
1
 
 integrin cy-
toplasmic domain. The interaction between ICAP-1 
and 
 
b
 
1
 
 integrins is highly specific, as demonstrated by 
the lack of interaction between ICAP-1 and the cyto-
plasmic domains of other 
 
b
 
 integrins, and requires a 
conserved and functionally important NPXY sequence 
motif found in the COOH-terminal region of the 
 
b
 
1
 
 in-
tegrin cytoplasmic domain. Mutational studies reveal 
that Asn and Tyr of the NPXY motif and a Val residue 
located NH
 
2
 
-terminal to this motif are critical for the 
ICAP-1 binding. Two isoforms of ICAP-1, a 200–amino 
acid protein (ICAP-1
 
a
 
) and a shorter 150–amino acid 
protein (ICAP-1
 
b
 
), derived from alternatively spliced 
mRNA, are expressed in most cells. ICAP-1
 
a
 
 is a phos-
phoprotein and the extent of its phosphorylation is reg-
ulated by the cell–matrix interaction. First, an enhance-
ment of ICAP-1
 
a
 
 phosphorylation is observed when 
cells were plated on fibronectin-coated but not on non-
 
specific poly-
 
l
 
-lysine–coated surface. Second, the ex-
pression of a constitutively activated RhoA protein that 
disrupts the cell–matrix interaction results in dephos-
phorylation of ICAP-1
 
a
 
. The regulation of ICAP-1
 
a
 
 
phosphorylation by the cell–matrix interaction suggests 
an important role of ICAP-1 during integrin-dependent 
cell adhesion.
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1. 
 
Abbreviations used in this paper
 
: aa, amino acid; FAK, focal adhesion
molecule; FN, fibronectin; GST, glutathione-S-transferase; ICAP-1, inte-
grin cytoplasmic domain–associated protein-1; PLK, poly-
 
l
 
-lysine.
 
I
 
ntegrins
 
 comprise a family of heterodimeric cell ad-
hesion receptors responsible for attachment of cells to
the extracellular matrix or to specific cell surface
counterreceptors (Hynes, 1992). Each subunit consists of a
large extracellular domain that participates in the ligand
recognition, a transmembrane region, and a short cyto-
plasmic domain. In adherent cells, the ligand binding in-
duces recruitment of integrins to the focal adhesion
plaques or focal contacts, where actin cytoskeletons con-
verge onto the site of cell–extracellular matrix contact (for
review see Burridge and Chrzanowska-Wodnicka, 1996).
Studies have shown that the integrin-dependent cell adhe-
sion can be regulated either by direct affinity modulation
of integrins (Bennett and Vilaire, 1979; Altieri and Edg-
ington, 1988; Faull et al., 1993; Stewart et al., 1996) or by
clustering of integrins, which requires cytoskeletal rear-
rangement (Hermanoswki-Vosatka et al., 1988; Haver-
stick et al., 1992; van Kooyk et al., 1994; Stewart et al.,
1996). Either through recruitment of regulatory proteins
such as adaptor protein Shc or focal adhesion kinase
(FAK)
 
1
 
 to the focal contacts or by inducing reorganization
of actin cytoskeleton, integrins function as transmembrane
receptors for extracellular signals and participate in the ac-
tivation of cytoplasmic signaling cascade (for review see
Schwartz et al., 1995). The dependence of cell prolifera-
tion, prevention of apoptosis, and cell differentiation on
the cell–matrix interaction mediated by integrins illus-
trates the importance of this adhesion-dependent cell sig-
naling.
Although the cytoplasmic domains of integrins lack any
known enzymatic activity or sequence motif involved in
protein–protein interaction, studies have shown that the
short cytoplasmic tails of 
 
a
 
 or 
 
b
 
 subunits are important for
the regulation of integrin affinity and cytoskeletal interac-
tion (Sastry and Horwitz, 1993; Schwartz et al., 1995). The
cytoplasmic domains of different 
 
b
 
 subunits are similar in
size and sequence. Mutational analysis of the cytoplasmic
domain of integrin 
 
b
 
1
 
 has identified three regions that are
important for the recruitment of integrins to the focal con-
tacts (Marcantonio et al., 1990; Reszka et al., 1992). The
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first region, located in the membrane-proximal region, is
rich in charged residues and predicted to form an 
 
a
 
-helical
structure. The second and third region consist of short se-
quences Asn-Pro-X-Tyr (NPXY). The NPXY motif was ini-
tially recognized as a sequence motif required for receptor-
mediated endocytosis (Chen et al., 1990) and represents a
unique structural motif capable of generating a reverse
turn in solution (Bansal and Gierasch, 1991). The two tan-
dem NPXY motifs of the integrins are situated in the
membrane-distal region that is known to undergo alterna-
tive splicing (Languino and Ruoslahti, 1992; Zhidkova et
al., 1995). Naturally occurring splicing variants of the 
 
b
 
1
 
 in-
tegrin lacking the NPXY motifs do not localize to the focal
contacts (Balzac et al., 1993). The first NPXY motif (mem-
brane-proximal), in addition to playing a role in integrin–
cytoskeleton interaction (Reszka et al., 1992; Ylanne et al.,
1995), is also involved in affinity regulation of integrins
(O’Toole et al., 1995) and integrin-dependent endocytic
processes (Van Nhieu et al., 1996). Mutational studies
have shown that the second NPXY motif (membrane-dis-
tal), like the first NPXY motif, is important for the focal
contact localization of 
 
b
 
1
 
 integrins (Reszka et al., 1992)
and cell adhesion by the 
 
b
 
2
 
 integrins (Hibbs et al., 1991;
Peter and O’Toole, 1995).
How the integrin 
 
b
 
 subunit cytoplasmic domain partici-
pates in the regulation of cell–matrix interaction has not
been resolved. The initial molecular models for the adhe-
sion-dependent recruitment of integrins to the focal con-
tacts were based on the observation that talin (Horwitz et
al., 1986) and 
 
a
 
-actinin (Otey et al., 1990) bind to the 
 
b
 
1
 
 in-
tegrins. As both of these proteins can bind actin, either di-
rectly as in 
 
a
 
-actinin or through interaction with vinculin
as in talin, the proposed function of talin and 
 
a
 
-actinin in
linking integrins to the cytoskeletal structures remains an
attractive model. Other proteins that have been shown to
bind 
 
b
 
1
 
 integrins include FAK (Schaller et al., 1995), paxil-
lin (Schaller et al., 1995), and a Ser/Thr kinase (ILK-1)
(Hannigan et al., 1996). Of these proteins, FAK and
ILK-1, because of their ability to affect cell adhesion and
cell spreading, represent potential regulators of the inte-
grin–matrix interaction.
A second unresolved issue is whether the adhesive func-
tion and cytoskeletal interaction of different integrins are
regulated by a common mechanism or by similar but dis-
tinct processes. Despite the remarkable similarities in the
amino acid sequences of different integrin 
 
b
 
 subunit cyto-
plasmic domains, each 
 
b
 
 subunit displays distinct differ-
ences in its ability to localize to the focal contacts (Wayner
et al., 1991; LaFlamme et al., 1994), to induce tyrosine
phosphorylation of cytoplasmic proteins upon surface
clustering (Freedman et al., 1993), and to participate in
gene induction (Yurochko et al., 1992). In particular, a di-
rect comparison of 
 
b
 
1
 
 and 
 
b
 
5
 
 cytoplasmic domains using a
chimeric 
 
b
 
1
 
–
 
b
 
5
 
 construct where the cytoplasmic domain of
 
b
 
1
 
 was replaced with that of 
 
b
 
5
 
 has demonstrated that the
 
b
 
5
 
 cytoplasmic domain, unlike the 
 
b
 
1
 
 counterpart, does not
efficiently direct integrins to the focal contact or promote
cell proliferation (Pasqualini and Hemler, 1994). Recently
identified 
 
b
 
3
 
-endonexin (Shattil et al., 1995) and cyto-
hesin-1 (Kolanus et al., 1996), which display restricted
binding to the 
 
b
 
3
 
 and 
 
b
 
2
 
 cytoplasmic domain, respectively,
suggest the presence of proteins that can discriminate the
subtle differences in the amino acid sequence of different
 
b
 
 subunits. These 
 
b
 
 subunit cytoplasmic domain–specific
binding proteins may allow specific regulation of individ-
ual 
 
b
 
 subunits.
In the present study, we report a novel polypeptide
named ICAP-1
 
a
 
 (integrin cytoplasmic domain–associated
protein-1) that binds to the 
 
b
 
1
 
 integrin cytoplasmic do-
main. The interaction, which can be demonstrated both in
vitro and in vivo, is specific for the 
 
b
 
1
 
 integrins and re-
quires the Asn and Tyr residues of the membrane-distal
NPXY motif. The ability of ICAP-1
 
a
 
 to interact only with
the 
 
b
 
1
 
 cytoplasmic domain is attributed to an additional
requirement of Val residue NH
 
2
 
-terminal to the NPXY.
The functional role of ICAP-1 in cell adhesion is suggested
by the observation that ICAP-1
 
a
 
 is a phosphoprotein and
that the degree of phosphorylation is regulated by inte-
grin-dependent, cell–matrix interaction.
 
Materials and Methods
 
Cell Lines and Antibodies
 
293, HeLa, Jurkat, K562, and Cos-7 cells were obtained from American
Type Culture Collection (Rockville, MD). SaOS, Rat-1, NIH3T3, 2f-TGH
(human fibroblast cells), and UTA-6 (Englert et al., 1995) were gifts
from C. Sawyers (University of California, Los Angeles, CA [UCLA]),
K. Shuai (UCLA), and D. Haber (Massachusetts General Hospital, Bos-
ton, MA).
Cells expressing constitutively activated RhoA were generated using
UTA-6 (Englert et al., 1995), a derivative of U2OS cells (osteosarcoma
cell line) expressing tetracycline-repressible transactivator (Gossen and
Bujard, 1992). An NH
 
2
 
-terminal FLAG epitope–tagged RhoA(Q63L)
(Coso et al., 1995) was cloned into pTPH-1 (Gossen and Bujard, 1992).
The expression construct was introduced into UTA-6 cells using a
Ca
 
2
 
PO
 
4
 
-precipitation method (Ausubel et al., 1994) and hygromycin-
resistant clones were isolated in the presence of 1 
 
m
 
g/ml tetracycline.
An anti-
 
b
 
1
 
 integrin mAb producing hybridoma cell line, TS2/16, was
generously provided by M. Hemler (Dana Farber Cancer Institute, Bos-
ton, MA). A mouse hybridoma cell line TS1/18 producing anti-
 
b
 
1
 
 integrin
mAb were obtained from ATCC. Hybridoma cell lines were cultured in
DME 
 
1
 
 10% CPSR-3 (Sigma Chemical Co., St. Louis, MO). mAb from
tissue culture supernatant was purified on protein A–Sepharose (Pharma-
cia LKB Biotechnology, Inc., Piscataway, NJ).
Polyclonal rabbit antisera against the 
 
a
 
 subunit of LFA-1 (
 
a
 
L
 
b
 
2
 
) were
prepared by immunizing rabbits with bacterially expressed glutathione-
S-transferase (GST) fusion protein containing the entire 58–amino acid
(aa) cytoplasmic domain (aa 1,088–1,145). For the generation of rabbit an-
tisera against ICAP-1, the entire ICAP-1
 
a
 
 coding sequences were cloned
in pET16b (Novagen Inc., Madison, WI) and expressed as a histidine-
tagged protein in 
 
Escherichia coli
 
 DE21 (Studier and Moffatt, 1986). His-
tagged ICAP-1
 
a
 
 was purified on nickel charged column (Novagen Inc.)
under denaturing conditions following the manufacturer’s recommenda-
tions and used as the immunogen.
 
Yeast Genetic Screening
 
The yeast genetic screening for the isolation of proteins interacting with
the cytoplasmic domain of 
 
b
 
1
 
 integrin was carried out essentially as de-
scribed previously (Gyuris et al., 1993). COOH-terminal 21 aa (GEN-
PIYKSAVTTVVNPXYEGK) of the 
 
b
 
1
 
 subunit was cloned in frame into
LexA coding sequence to generate a “bait” plasmid pNlex-
 
b
 
1
 
cyto. The re-
sulting Lex-
 
b
 
1
 
cyto fusion protein was able to bind LexA operator in yeast,
but displayed no basal transcriptional activity. A yeast expression library
was generated from oligo dT-primed cDNA from JY cell (human B cell
line) mRNA. The cDNA was cloned unidirectionally into the EcoRI/
XhoI sites of a yeast expression vector pJG4-5. This cDNA library that
had the complexity of 
 
.
 
10
 
6
 
 was amplified once and used to transform a
yeast strain EGY48 harboring pNlex-
 
b
 
1
 
cyto and JK103 lacZ reporter plas-
mid. Approximately 2 
 
3
 
 10
 
6
 
 independent yeast transformants were
pooled and subjected to selection as described. Eight positive clones ob-
tained all had identical cDNA insert. Plasmid DNA from one isolate 
Chang et al. 
 
b
 
1
 
 Integrin Cytoplasmic Domain–associated Protein
 
1151
 
(Clone E16-1) was rescued using 
 
E. coli
 
 KC8 (Gyuris et al., 1993) and am-
plified for further analysis. All bait constructs containing various integrin
cytoplasmic domains or 
 
b
 
1
 
 integrin cytoplasmic domain mutants were
tested for proper expression in a “suppression assay” in yeast using a re-
porter construct JK101 (Gyuris et al., 1993). 
 
b
 
-galactosidase activity mea-
surement was carried out as described previously (Ausubel, 1994).
 
Northern Blot Analysis and cDNA Cloning
 
The cDNA insert from Clone E16-1 was used as the probe to screen a
multiple tissue mRNA blot (Clontech, Palo Alto, CA). A full-length
cDNA was isolated from a HeLa cell cDNA library (a gift from K. Shuai,
UCLA) using Clone E16-1 as the probe. An expressed sequence tag
(EST) clone corresponding to ICAP-1
 
b
 
 was obtained from the IMAGE
Consortium (these sequence data are available EMBL/GenBank/DDBJ
under accession number T69975). The presence of cDNA corresponding
to ICAP-1
 
b
 
 was independently confirmed by PCR (40 cycles: 94
 
8
 
C for 45 s;
55
 
8
 
C for 45 s; 72
 
8
 
C for 30 s) using primers A3 (5
 
9
 
-CCCAGCAAGATG-
GAAAGTTGCC-3
 
9
 
) and B2 (5
 
9
 
-GATCAGCATTTTACACAATCCA-
3
 
9
 
) flanking the deleted sequences, which generated a 459- (ICAP-1
 
a
 
) or a
shorter 308-bp fragment (ICAP-1
 
b
 
).
 
In Vitro Interaction Assay
 
For in vitro GST “pull-down” experiments, the COOH-terminal cytoplas-
mic domains of 
 
b
 
1
 
 subunit (see above), 
 
b
 
2
 
 subunit (DNPLFKSATTTVM-
NPKFAES), and 
 
a
 
L
 
 (KVGFFKRNLKEKMEAGRGVPNGIPAEDSE-
QLASGQEAGDPGCLKPLHEKDSESGGGD) were individually ex-
pressed in bacteria as GST fusion proteins. The EcoRI/XhoI insert of
Clone E16-1 encoding ICAP-1
 
a
 
 (aa 54–200) was cloned into the EcoRI/
XhoI site of an in vitro transcription vector pCITE-3a (Novagen, Inc.).
The resulting pCITE-ICAP1
 
a
 
 plasmid was used as the template in
cotranscription/translation reaction using T7 RNA polymerase and rabbit
reticulocyte lysate (Promega Corp., Madison, WI) to generate [
 
35
 
S]me-
thionine-labeled polypeptides. An equal amount of labeled polypeptides
was added to 
 
z
 
2 
 
m
 
g of GST fusion proteins bound on glutathione-
Sepharose beads (Pharmacia LKB Biotechnology Inc.) and incubated
overnight at 4
 
8
 
C in NET (25 mM Tris-HCl, pH 7.6, 100 mM NaCl, 3 mM
EDTA) containing 1 mM DTT, 1% BSA, and 0.1% Triton X-100. Beads
were washed twice in the binding buffer and twice in 0.05% Triton X-100
in NET. Bound proteins were eluted by boiling in SDS sample buffer and
analyzed by SDS gel electrophoresis.
 
Eukaryotic Expression Plasmids
The coding sequences of human aL integrin (CD11a) and human b2
(CD18) from the expression vectors previously described (Hibbs et al.,
1991) were cloned into the XbaI site of the eukaryotic expression vector
pcDNA3 (Invitrogen Inc., Madison, WI). To construct a hybrid b2.1 sub-
unit, two PCR-generated fragments corresponding to the amino acids
634–749 of b2 and amino acids 778–798 of b1 were ligated together using a
XcmI site that was introduced during the PCR. This fragment was cloned
into the BstBI and NotI site of pcDNA3/b2 to generate pcDNA/b2.1. The
sequence of the cytoplasmic domain in this hybrid b2.1 subunit consists
of NH3-KALIHLSDLREYRRFEKEKLKSQWNGENPIYKSAVTTVV-
NPXYEGK-COOH.
The full-length ICAP-1a cDNA was cloned into the EcoRV site of
pcDNA3 to generate pcDNA/ICAP-1a. To generate the full-length
ICAP-1b coding sequence, the 59 half of the above PCR fragment and the
39 half of a second PCR fragment amplified from T69975 clone (see
above) were ligated in frame using a unique HpaII restriction site. The li-
gation product was cloned into the EcoRV site of pcDNA3 to produce
pcDNA/ICAP-1b. The GST-tagged ICAP-1 constructs were generated
using eukaryotic expression vector pEBG. The coding sequence of the
partial ICAP-1a (aa 54–200) was derived from Clone E16-1.
Eukaryotic Expression and In Vivo Interaction Assay
5–10  mg of plasmid DNA was transfected into 293T cells by using a
Ca2PO4 precipitation method (Ausubel et al., 1994). 48 h after transfec-
tion, cells were lysed in TBSM (25 mM Tris-HCl, pH 7.6, 150 mM NaCl,
and 2 mM MgCl2) containing 0.5% NP-40, leupeptin, aprotinin, and
PMSF. Detergent insoluble materials were removed by centrifugation at
12,000 g for 15 min. 500 mg of cleared lysates were mixed with an equal
volume of TBSM to reduce the final detergent concentration to 0.25%
NP-40 and incubated with glutathione–Sepharose beads for 3 h at 48C.
Beads were washed with TBSM 1 0.25% NP-40 once, TBSM 1 0.1% NP-
40 twice, and TBSM alone twice. Coprecipitation of b1 integrins with
bound GST-ICAP1 was determined on a Western analysis using mAb
TS2/16 (anti-b1 integrin).
In Vitro Phosphatase Assay
50 mg NP-40 detergent lysate in 40 ml of 25 mM Tris-HCl, pH 8.0, 50 mM
NaCl, and 10 mM MgCl2, was incubated at 308C for 30 min, either in the
presence or absence of phosphatase inhibitors (1 mM NaVO3 and 0.5 mM
calyculin A). The reaction was terminated by adding SDS sample buffer
and boiling for 5 min. 15 mg of lysates were analyzed on Western blot us-
ing anti-ICAP1 antibody.
Adhesion Assay
Cell adhesion was carried out using six-well tissue culture plates. Each 35-
mm well was coated with 1 ml of fibronectin (20 mg/ml) or poly-l-lysine
(PLK) (50 mg/ml) in TBS (25 mM Tris-HCl, pH 8.0, 150 mM NaCl) over-
night at 378C. The coated wells were subsequently blocked with 1% BSA
(Faction V; GIBCO BRL, Gaithersburg, MD) in TBS before the addition
of cells. Adhesion was carried out using 5 3 105 cells per well at 378C for
15–30 min and bound cells were lysed in 0.2% SDS in TE (25 mM Tris-
HCl, pH 8.0, 1 mM EDTA).
Results
Cloning of ICAP-1
A genetic screening based on the protein–protein interac-
tion in yeast (Gyuris et al., 1993) was used to identify
polypeptides that interact with the b1 integrin cytoplasmic
domain. Of the 47 aa that comprise the entire b1 integrin
cytoplasmic domain, the COOH-terminal 21 aa were
cloned in frame into the DNA-binding domain of bacterial
protein LexA. Mutational studies and analysis of naturally
occurring splicing variants lacking this 21-aa region have
shown that this region is involved in the localization of b1
integrins to the focal contacts and proper adhesive func-
tion of integrins (Balzac et al., 1993; Meredith et al., 1995).
Using the COOH-terminal 21 aa of integrin b1 as the
bait, a z1.1-kb partial cDNA was isolated in a yeast two-
hybrid screening of a human B cell cDNA library. This
partial cDNA insert was used to obtain a full-length
cDNA encoding a polypeptide of 200 aa. In a yeast two-
hybrid assay, both the original partial cDNA (aa 154–200)
and the full-length cDNA exhibited comparable interac-
tion with the b1 integrin cytoplasmic domain but not with
unrelated baits (Table I). In addition, the partial or full-
length cDNA clones interacted with baits containing ei-
ther the b1 integrin COOH-terminal 21 aa or a longer 47
aa that comprise the complete cytoplasmic domain. The
interaction was specific towards only the b1 integrin as nei-
ther the partial nor the full-length cDNA clone interacted
with the b2, b3, or b5 integrin cytoplasmic domain. The iso-
lated clone hereon will be referred as ICAP-1a.
The deduced amino acid sequence of ICAP-1a was un-
revealing except for the preponderance (especially in the
NH2-terminal region) of Ser and Thr, several of which rep-
resented potential phosphorylation sites (Fig. 1 A). In par-
ticular, Ser20, Ser46, and Ser197 represent potential phos-
phorylation sites by protein kinase C (Woodgett et al.,
1986), and Ser10 is present in sequence context favorable
for phosphorylation by cyclic nucleotide dependent pro-
tein kinases (Glass et al., 1986). The initiation codon ATG
in the sequence was preceded by an in frame terminationThe Journal of Cell Biology, Volume 138, 1997 1152
codon and was present in correct sequence context for
translational initiation (Kozak, 1992). Although clones
corresponding to the ICAP-1a cDNA were represented in
the National Center for Biotechnology Information (NCBI)
EST database, analyses of the NCBI Non-Redundant da-
tabase using the BLAST Enhanced Alignment Utility al-
gorithm failed to identify any significant similarities to
known proteins.
In Northern analyses, ICAP-1a transcripts of 0.9 and 1.3
kb in size were detected in mRNA isolated from several
tissues (Fig. 1 B). The b1 integrins are ubiquitously ex-
pressed and ICAP-1, as a b1 integrin–binding protein, is
expected to have a similar broad expression in various tis-
sues and cell lines. The differences in the size of two tran-
scripts probably reflect the usage of two different polyade-
nylation sites observed during cDNA sequence analysis.
In Western analyses using polyclonal anti-ICAP1 anti-
bodies, two distinct polypeptides of 20 and 16 kd were de-
tected (Fig. 1 C, lane 1). In hypotonic cell lysis, ICAP-1a
fractionates in the cytosolic fraction suggesting ICAP-1a is
a cytoplasmic protein (data not shown). Expression of
ICAP-1a cDNA in 293T cells produced the exact 20-kD
polypeptides (Fig. 1 C, lane 2). The shorter 16-kD species
likely represent ICAP-1b, an alternatively spliced variant
of ICAP-1a lacking internal 50 aa (Fig. 1 D). A cDNA
corresponding to ICAP-1b mRNA was recognized during
the database search. The presence of ICAP-1b cDNA in
several human cDNA libraries was subsequently con-
firmed by PCR analyses (data not shown). The expression
of ICAP-1b cDNA in 293T cells, as expected, produced
the exact 16-kD polypeptide that comigrated with the en-
dogenous ICAP-1b polypeptides (Fig. 1 C, lane 3). Inter-
estingly, ICAP-1b did not interact with the integrin b1 cy-
toplasmic domain in a yeast two-hybrid assay (data not
shown).
b1 Integrin Cytoplasmic Domain Restricted Binding
of ICAP-1a
To verify the specific interaction between ICAP-1a and
the b1 integrin cytoplasmic domain seen in the yeast ge-
netic screening, in vitro–translated ICAP-1a was incu-
bated with various integrin cytoplasmic domains ex-
pressed in bacteria as GST fusion proteins (Fig. 2 A).
After incubation, GST fusion proteins were isolated on
glutathione–Sepharose beads and the bound ICAP-1a
polypeptides were analyzed by a SDS gel electrophoresis.
As in a yeast two-hybrid assay, ICAP-1a was bound only
to the GST-b1 fusion protein and not to the GST-b2 or
GST-aL fusion proteins.
Reciprocal GST pull-down experiments were used to
demonstrate the interaction between ICAP-1a and endog-
enous b1 integrins in vivo. GST epitope-tagged ICAP-1a
was transiently expressed in 293T cells. Glutathione–
Sepharose beads were used to purified GST-ICAP1a and
copurification of endogenous b1 integrins was tested on a
Western analysis using anti-b1 antibody. Confirming the
results of the yeast two-hybrid assays and in vitro binding
studies, b1 integrins copurified with GST-ICAP1a, but not
with unrelated GST fusion proteins or GST alone (Fig. 2 B).
Figure 1. ICAP-1a is a novel serine/threonine-rich 20-kD pro-
tein. (A) Sequence of ICAP-1. The translated amino acid se-
quence of ICAP-1a is shown. 50 amino acids absent in ICAP-1b
are indicated in underlined italics. The nucleotide sequence data
are available from GenBank/EMBL/DDBJ under accession
number AF012023. (B) Northern blot analysis of ICAP-1a.
Northern blots of transcripts from various human tissues (Clon-
tech) were hybridized with ICAP-1a cDNA probe. The 0.9-kb
mRNA is expressed in all eight tissue samples. The minor 1.3-kb
mRNA, derived from the use of the downstream polyadenylation
site, is also expressed in varying amount in all eight samples. (C)
Western blot analysis of ICAP-1. ICAP-1a and ICAP-1b were
detected in the total cell lysate (5 mg) from 293T cells using poly-
clonal anti-ICAP-1 antibody (lane 1). The assignments of ICAP-
1a and ICAP-1b were confirmed by transiently expressing ICAP-
1a (lane 2) and ICAP-1b cDNA (lane 3) in 293T cells. (D) The
full-length 200-aa ICAP-1a and an alternatively spliced ICAP-1b
lacking internal 50 aa are shown in a schematic diagram.
Figure 2. In vitro and in vivo interaction between ICAP-1a and
b1 integrins. (A) Interaction between GST-b1 and ICAP-1a in
vitro. ICAP-1a (aa 54–200) was synthesized in vitro using reticu-
locyte lysate (lane 1) and incubated with 2 mg of bacterially ex-
pressed GST fusion proteins containing the cytoplasmic domains
of integrin b1 (lane 2), b2 (lane 3), and aL (lane 4). (B) Interaction
between GST-ICAP1a and b1 integrins in vivo. ICAP-1a (aa 54–
200) (lane 1) and a full-length ICAP1a (lane 2) were expressed as
GST fusion protein in 293T cells using eukaryotic expression vec-
tor pEBG. For controls, GST-Stat1 (lane 3) and GST (lane 4)
were used. Coprecipitation of the endogenous b1 integrins with
the GST fusion proteins were determined on a Western blot us-
ing TS2/16 (anti–human b1 integrin antibody). (C) Restricted
binding specificity of ICAP1a. GST-ICAP1a was expressed in
293T cells along with expression constructs for aLb2 or aLb2-1
(chimeric b2 subunit that has the COOH-terminal 20 aa replaced
with the COOH-terminal 21 aa of b1 integrin). Coprecipitation of
transfected integrins with the GST-ICAP1a was determined on a
Western blot using anti-aL antibody. Lanes 1 and 2, total lysates
of cells expressing GST-ICAP1a and aLb2 (lane 1) and aLb2-1
(lane 2). Lanes 3 and 4, the same samples as in lanes 1 and 2, re-
spectively, after GST “pull-down.”Chang et al. b1 Integrin Cytoplasmic Domain–associated Protein 1153
Finally, to demonstrate that ICAP-1a is a specific b1 in-
tegrin binding protein in vivo, GST epitope-tagged ICAP-1a
was coexpressed in 293T cells with the integrin b2 subunit
or a chimeric b2 subunit (b2.1) constructed by replacing the
COOH-terminal 20 aa region of the b2 subunit with the
corresponding sequences of the b1 subunit. The expression
of b2 integrins is limited to cells of hematopoietic origin
and 293T cells completely lack expression of b2 integrins
(Liu, J., and D. Chang, unpublished observation). To en-
sure a proper cell surface expression, the aL subunit capa-
ble of forming stable heterodimer with the b2 subunit was
also expressed. A comparable surface expression of aLb2 and
aLb2.1 was seen on FACS® analysis (data not shown). Af-
ter precipitation of GST-ICAP1a on glutathione–Sepharose
beads, copurification of b2 integrin was indirectly tested
in Western analysis using anti-aL antibody. In GST pull-
down experiments, as predicted from the yeast two-hybrid
assays and in vitro binding assays, only aLb2.1 and not aLb2
copurified with ICAP-1a (Fig. 2 C). These findings dem-
onstrate the ability of ICAP-1a to interact with integrin
ab heterodimer in a b1 cytoplasmic domain-dependent
fashion.
Conserved NPXY Motif of Integrin b1 Cytoplasmic 
Domain is Required for the ICAP-1a Binding
ICAP-1a interacts with the b1 integrins through the
COOH-terminal 21 aa region. Naturally occurring, alter-
natively spliced variants of b1 integrins, which lack this re-
gion or mutant b1 integrins containing amino acid substitu-
tions at either of the two conserved NPXY motifs do not
localize to the focal contacts (Reszka et al., 1992; Balzac et
al., 1993). Furthermore, mutations in the analogous region
of  b2 or b3 integrins affect the leukocyte integrin aLb2
(LFA-1)-dependent cell adhesion to intercellular cell ad-
hesion molecules-1 or the affinity regulation of the platelet
integrin aIIbb3 (Hibbs et al., 1991; O’Toole et al., 1995; Pe-
ter and O’Toole, 1995).
The exact ICAP-1a binding site within the b1 integrin
cytoplasmic domain was further delineated by testing the
interaction between ICAP-1a and truncated b1 integrin
cytoplasmic domain (Table II). NH2-terminal deletions up
to 8 aa did not affect the interaction with ICAP-1a. A 3-aa
deletion in the COOH terminus, however, completely
abolished the interaction. Therefore, a minimum binding
site for ICAP-1a on the b1 integrin cytoplasmic must con-
sist of this 13-aa region that included one of the two
NPXY motifs. The NPXY motif is required for the inter-
action as amino acid substitutions at the conserved Asn to
Glu or Ala abolished the binding. Similarly, a substitution
of Tyr to Ala disrupted the ICAP-1a binding whereas a
more conservative replacement of Tyr to Phe had no ef-
fect.
In yeast interaction and in vitro binding assays,
ICAP-1a failed to interact with the b2 integrin cytoplasmic
domain, which is closely related to the b1 integrin cytoplas-
mic domain in sequence (Table III). The molecular basis
of this highly discriminatory binding specificity of ICAP-1a
was investigated by progressively mutating the b2 integrin
cytoplasmic domain. There are two conserved and four
nonconserved amino acid differences between the b1 and
b2 integrins within the minimum 13 aa ICAP-1a binding
region. A replacement of three consecutive nonconserved
residues found in the COOH terminus of b2 integrin from
Ala-Glu-Ser to Glu-Gly-Lys found in the b1 subunit did
not allow the ICAP-1a binding. Interestingly, a single
amino acid replacement at the 211 position from Thr to
Val allowed the mutant b2 integrin to interact with ICAP-
1a, demonstrating that in addition to the NPXY motif, Val
at the 211 position is essential for the interaction between
b1 integrins and ICAP-1a.
ICAP-1a Is a Phosphoprotein
In addition to the 20- and 16-kD polypeptides correspond-
ing to ICAP-1a and ICAP-1b, heterogeneous bands mi-
grating slower than the 20-kD band were detected in
Western analysis of 293T cell lysates using polyclonal anti-
ICAP1 antisera (data not shown). Because the amino acid
composition of ICAP-1 is rich in Ser and Thr, the possibil-
ity that this mobility difference is due to protein phosphor-
ylation was raised. When total detergent lysates of several
Table I. ICAP1: Integrin Cytoplasmic Domain Interaction in Yeast Genetic Screen
Baits Sequence* Interaction‡ b-gal. Activity§
b1cyto KLLMIIHDRREFAKFEKEKMNAKWDTGENPIYKSAVTTVVNPKYEGK 1 ND
b2cyto KALIHLSDLREYRRFEKEKLKSQWNN DNPLFKSATTTVMNPKFAES 2, 1.0
b1(E16) GENPIYKSAVTTVVNPKYEGK 1 149.5 6 18.3
b2(E16) DNPLFKSATTTVMNPKFAES 2, 1.0
b3(E16) ANNPLYKEATSTFTNITYRGT 2, 1.0
b5(E16) ASNPLYRKPISTHTVDFTFNKSYNGTVD 2 2.41 6 3.0
aL KVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLASGQEAGDPGCLKPLHEKDSESGGGD 2, 1.0
a2 KVGFFKRKYEKMTKNPDEIDETTELSS 2 ND
*The conserved NPXY motifs of integrin b chains are indicated in bold letters. b1 cyto, complete cytoplasmic domain of integrin b1. b1(E16), COOH-terminal 21 aa of integrin
b1. aL, complete cytoplasmic domain of integrin aL. 
‡Positive interaction denotes growth of blue colonies on X-gal indicator plates lacking leucine. 
§b-galactosidase activity was derived from a minimum four independent measurements.
Table II. ICAP1: b1 Subunit Deletion Mutant Interaction
Baits Sequence* Interaction‡
b1(E16) GENPIYKSAVTTVVNPKYEGK 1
b1ND-3 IYKSAVTTVVNPKYEGK 1
b1ND-8 AVTTVVNPKYEGK 1
b1CD-3 GENPIYKSAVTTVVNPKY 2
b1EGK®AES GENPIYKSAVTTVVNPKYAES 1
*The conserved NPXY motifs of integrin b chain are indicated in bold letters.
‡Positive interaction denotes growth of blue colonies on X-gal indicator plates lacking
leucine.The Journal of Cell Biology, Volume 138, 1997 1154
different cell lines were surveyed by Western analysis,
there was a significant variation in the relative amount of
slow migrating species (Fig. 3 A). In particular, two os-
teosarcoma cell lines, SaOS (Fig. 3 A, lane 2) and UTA-6
(Fig. 3 A, lane 3), displayed high abundance of the slow
migrating species. To directly confirm that the slow mi-
grating species represented phosphorylated forms of
ICAP-1a, UTA-6 cell lysates incubated at 308C to activate
endogenous phosphatases (Fig. 3 B). The slow migrating
species disappeared with a concomitant increase in the 20
kD ICAP-1a upon 308C incubation (Fig. 3 B, lane 3). The
addition of phosphatase inhibitors, sodium vanadate, and
calyculin A, completely prevented the conversion of the
slow migrating species to the 20 kD ICAP-1a (Fig. 3 B,
lanes 2 and 4), confirming the mobility difference is due to
protein phosphorylation. Interestingly, during in vitro
phosphatase experiment, we failed to detect any mobility
shift in ICAP-1b, suggesting that either ICAP-1b is not
phosphorylated or the mobility of ICAP-1b does not
change significantly by protein phosphorylation.
Regulation of ICAP-1a Phosphorylation by
Integrin-dependent Cell–Matrix Interaction
Many focal contact proteins, FAK, paxillin, and tensin be-
ing a few representative ones, have been shown to un-
dergo protein phosphorylation during cell attachment
(Clark and Brugge, 1995). The possibility that the phos-
phorylation of ICAP-1a may be regulated in a similar
manner during cell attachment was directly addressed by
binding UTA-6 cells to either PLK or fibronectin (FN)-
coated surface (Fig. 4). Western analyses of cell lysates re-
vealed an enhanced phosphorylation of ICAP-1a when
cells adhere to the FN-coated surface. The maximum en-
hancement occurred within the minimum 30 min required
for sufficient number of cells to adhere and undergo cell
spreading (Fig. 4, lanes 2 and 4). A longer incubation did
not further enhance ICAP-1a phosphorylation (data not
shown). This enhancement was specific for cell attachment
to FN-coated surface, which requires b1 integrins. On
PLK-coated surface, cells adhere very efficiently, but fail
to initiate subsequent cell spreading. Under these condi-
tions, the phosphorylation of ICAP-1a remained at a re-
duced level (Fig. 4, lanes 1 and 3).
During integrin-dependent cell adhesion, the rearrange-
ment of cytoskeletal actin stress fibers and assembly of fo-
cal adhesion plaques are regulated by Rho-family GTPases
(Hall, 1994; Burridge and Chrzanowska-Wodnicka, 1996).
In UTA-6 derivative cell lines expressing constitutively
activated RhoA(Q63L) under the control of tetracycline-
inducible system, the induction of RhoA(Q63L) expres-
sion results in the formation of dense stress fibers and in-
crease in the number of focal adhesion plaques (Wong, C.,
and D. Chang, manuscript in preparation). These cells dis-
play a significantly delayed and incomplete cell spreading
when plated on FN-coated surface (Fig. 5 A). To test
whether the alteration in cell–matrix interaction induced
by the expression of RhoA(Q63L) had any effect on the
phosphorylation status of ICAP-1a, a Western analysis
was carried out using the lysates from RhoA(Q63L) ex-
pressing cells. The lysates prepared from cells grown in the
presence of tetracycline, which represses the expression of
RhoA(Q63L), were used as controls. Fig. 5 B shows that
the expression of constitutively activated RhoA(Q63L) re-
duces the extent of ICAP-1a phosphorylation in two inde-
pendently derived cell lines. Thus, taken together, these find-
ings suggest that phosphorylation of ICAP-1a is regulated
during integrin-dependent cell adhesion and spreading.
Discussion
Integrins, through binding to both extracellular matrix
proteins and cytoskeletal structures, provide a direct link-
Table III. ICAP1: b1 and b2 Subunit Point Mutant Interaction
Baits Sequence* Interaction‡
b1V787A .A........... 2
b1N792A ......A...... 2
b1N792D ......D...... 2
b1Y792A .........A... 2
b1Y792F .........F... 1
b1ND-8 AVTTVVNPKYEGK 1
| |||||||•
b2ND-8 ATTTVVNPKFAES 2
b2AES/EGK ..........EGK 2
b2F766Y .........Y... 2
b2T758V .V........... 1
*The amino acid replaced in each b1 integrin mutant is indicated. Dots denote the se-
quences that are identical to the b1ND-8 or b2ND-8 sequences.
‡Positive interaction denotes growth of blue colonies on X-gal indicator plates lacking
leucine.
Figure 3. ICAP-1a is a phosphoprotein. (A) Western blot analy-
sis showing ICAP-1 expression. Total cell lysates (15 mg) from
various cell lines were analyzed on a Western blot using anti-
ICAP1 antibody. The positions of ICAP-1a and ICAP-1b as well
as the slow migrating species corresponding to the phosphory-
lated ICAP-1a ( p-ICAP1a) are indicated. (B) In vitro phos-
phatase treatment experiment. 15 mg of UTA-6 cell lysates were
incubated at 308C for 30 min. Lane 1, input; lane 2, incubation in
the presence of sodium vanadate and calyculin A; lane 3, incuba-
tion at 308C.
Figure 4. Regulation of
ICAP-1a phosphorylation
during cell adhesion. UTA-6
cells were trypsinized and re-
plated on plates coated with
poly-l-lysine (PLK) (lanes 1
and  3) or fibronectin (FN)
(lanes  2 and 4). Adherent cells were lysed in 0.5% NP-40 at t 5
15 min (lanes 1 and 2), and t 5 30 min (lanes 3 and 4) and the ex-
tent of ICAP-1a phosphorylation was determined on a Western
blot using anti-ICAP-1 antibody.Chang et al. b1 Integrin Cytoplasmic Domain–associated Protein 1155
age between the extracellular environment and the cell in-
terior. The cytoplasmic domains of integrins have been im-
plicated in the integrin affinity regulation and localization
of integrins to the focal contacts. Understanding how the
short cytoplasmic tails of integrins affect the functions of
integrins requires characterization of cellular proteins that
bind, either directly or indirectly, to the integrin cytoplas-
mic domains. To this end, we have used a yeast two-hybrid
screen to identify proteins that directly bind to the b1 inte-
grin cytoplasmic domain. In particular, we have focused
on the COOH-terminal 21-aa region of the b1 integrin,
which is required for the localization of integrins to the fo-
cal contacts. In this study, we report identification and
characterization of ICAP-1a, a novel 200-aa protein that
specifically interacts with the b1 integrin cytoplasmic do-
main through a conserved and functionally important
NPXY sequence motif. In addition, ICAP-1a undergoes
protein phosphorylation that is subject to regulation, sug-
gesting that ICAP-1a plays an important role during inte-
grin-dependent cell adhesion.
The broad tissue distribution of ICAP-1a mRNA and
the detection of ICAP-1a protein in cell lines of various
tissue origins indicate ICAP-1a, like b1 integrins, is ubiqui-
tously expressed. In contrast, the expression of ICAP-1b,
an alternatively spliced variant of ICAP-1a that does not
bind to the b1 integrin cytoplasmic domain, was more vari-
able in cell lines we have tested. In particular, the ICAP-
1b expression was low or absent in three cell lines, SaOS
(human osteosarcoma line), TPH-1 (human monocytic
line), and Cos-7 (monkey kidney line). The differences in
the ability to interact with the b1 cytoplasmic domain and
in the expression level provide a mechanism for regulation
of ICAP-1a function by ICAP-1b. It is noteworthy that b3-
endonexin likewise has an alternatively spliced variant
that does not interact with the b3 integrin cytoplasmic do-
main (Shattil et al., 1995).
The amino acid sequence of ICAP-1a is unique and dis-
plays no similarities to any known proteins. Several pro-
teins, including known focal contact proteins, a-actinin,
paxillin, talin, and FAK, as well as recently identified po-
tential regulatory proteins such as b3-endonexin, ILK-1,
and cytohesin-1 have been shown to bind integrins
through the b subunit cytoplasmic domain (for review see
Sastry and Horwitz, 1993; Shattil et al., 1995; Hannigan et
al., 1996; Kolanus et al., 1996). In contrary to a-actinin,
FAK, and ILK-1, which interact with more than one type
of b subunit, the interaction of ICAP-1a is restricted to the
b1 subunit only. This property of ICAP-1a is similar to two
recently identified proteins, b3-endonexin and cytohesin-1,
which bind specifically to integrins b3 and b2, respectively
(Shattil et al., 1995; Kolanus et al., 1996). As these proteins
are not related in sequence to each other or to ICAP-1a, it
remains to be seen how these unrelated proteins are cou-
pled to the b integrin cytoplasmic domains, which are re-
lated and functionally interchangeable in some cases.
The results from our mutagenesis studies indicate that
the COOH-terminal 13-aa region of the b1 subunit, which
includes a conserved NPXY motif, is sufficient to bind
ICAP-1a. Several studies have shown that this region, es-
pecially the NPXY motif, is important for the recruitment
of b1 integrins to the focal contacts (Marcantonio et al.,
1990; Reszka et al., 1992; Peter and O’Toole, 1995; Ylanne
et al., 1995) and the colocalization of talin, FAK, and actin
with b1 integrins (Lewis and Schwartz, 1995). Our finding
that Asn to Ala (or Glu), or Tyr to Ala substitution within
the NPXY motif completely abolished the interaction be-
tween ICAP-1a and integrins, while a more conservative
replacement of Tyr with Phe had no effect, demonstrates a
remarkable similarity between the sequence requirement
Figure 5. Control of ICAP-1a phosphorylation by RhoA protein.
(A) Expression of activated RhoA interferes with cell spreading.
The morphology of UTA-6 cells expressing RhoA(Q63L) under
the control of tetracycline-inducible promoter is shown. In the
absence of tetracycline, which induces the expression of RhoA
(Q63L), cells remain rounded and fail to spread. (B) Expression
of activated RhoA results in dephosphorylation of ICAP-1a. The
extent of ICAP-1a phosphorylation in two independently de-
rived UTA-6 cell lines expressing RhoA (Q63L) was assessed in
Western blot analysis using anti-ICAP1 antibody. In parental
cells (lane 1) or in the presence of tetracycline (lanes 2 and 4), a
significant portion of ICAP-1a is phosphorylated. Induction of
RhoA(Q63L) is associated with the loss of ICAP-1a phosphory-
lation is both cell lines (lanes 3 and 5).The Journal of Cell Biology, Volume 138, 1997 1156
for the binding of ICAP-1a to integrins and localization of
b1 integrins to the focal contacts and suggests that ICAP-
1a may play a role in the recruitment of b1 integrins to the
focal contacts. Alternatively, the COOH-terminal 13-aa
region may be involved in initiating signal transduction
events required to trigger cell spreading and ICAP-1a may
participate in the initiation of this signaling event. As b2,
b3, and b5 integrin cytoplasmic domains (which do not
bind ICAP-1a) can also direct integrins to the focal con-
tacts (LaFlamme et al., 1994; Peter and O’Toole, 1995),
there must be parallel mechanisms for recruiting various
integrins to the focal contacts.
The COOH-terminal regions of different b integrins are
somewhat diverse in amino acid sequence, which may ex-
plain in part the observed specificity of ICAP-1a interac-
tion with the b1 integrin cytoplasmic domain. The basis of
this restricted specificity, however, was attributed to a sin-
gle Val residue NH2-terminal to the conserved NPXY mo-
tif. In b2 or b3 subunits, the corresponding position is occu-
pied by Thr (Sastry and Horwitz, 1993). Confirming the
importance of Val at this position, the replacement of the
Thr with a Val in the b2 subunit cytoplasmic tail allowed it
to bind ICAP-1a. The b3 integrin cytoplasmic domain, in
addition, has a less conserved NITY in place of the NPXY
motif, which may also account for the lack of interaction
with ICAP-1a. A recent study on the amino acid sequence
requirement for the interaction between b3-endonexin and
b3 integrin cytoplasmic domain indicated that the NITY
motif is critical for the binding specificity (Eigenthaler et
al., 1997). Altogether these findings suggest that the
COOH-terminal regions of different b integrins may con-
stitute specific binding sites for different cytoplasmic pro-
teins. In addition, the existence of integrin b subunit spe-
cific binding proteins indicates that the functions of
individual subunits can be differentially regulated.
The presence of ICAP-1a immunoreacting species,
which migrated slower than the expected molecular
weight of 20 kD predicted from the ICAP-1a reading
frame suggested that ICAP-1a undergoes posttransla-
tional modification. The conversion of slower migrating
species to the expected 20-kD species during 308C incuba-
tion, which activates the endogenous phosphatases present
in nonionic detergent lysates, and the observation that this
conversion can be effectively blocked by the addition of
known phosphatase inhibitors demonstrate that ICAP-1a
is a phosphoprotein.
The most intriguing property of ICAP-1a is that its
phosphorylation is regulated during cell adhesion and by
RhoA protein. We suspect that the effect on ICAP-1a
phosphorylation seen during cell adhesion on FN-coated
surface and in cells expressing constitutively activated
RhoA(Q63L) are related events, reflective of the cytoskel-
etal rearrangement that occurs during cell adhesion. It is
well known that cells, soon after making an initial contact
on FN-coated surface, undergo cell spreading that involves
the formation of focal adhesion plaques and actin stress fi-
bers (for review see Hall, 1994). Both these events are
known to be regulated by RhoA (Ridley and Hall, 1992;
Nobes and Hall, 1995). Furthermore, both matrix assem-
bly and cell spreading are integrin-dependent processes
and require integrin cytoplasmic domain (for review see
Burridge and Chrzanowska-Wodnicka, 1996; LaFlamme
et al., 1994). On a nonspecific PLK-coated surface, cells
make initial contact but fail to promote matrix assembly
and initiate spreading. Cells expressing RhoA(Q61L) also
display a delayed and incomplete spreading, presumably
due to the interference from dense stress fibers. According
to this scenario, the diminished ICAP-1a phosphorylation
observed during cell adhesion on PLK-coated surface and
in RhoA(Q63L) expressing cells is a result of inefficient
cell spreading. Our findings, however, do not rule out the
possibility that phosphorylation of ICAP-1a may be a di-
rect consequence of the interaction between integrins and
fibronectin. Regardless of the exact mechanism underlying
the control of ICAP-1a phosphorylation, our data clearly
demonstrate that the phosphorylation of ICAP-1a is regu-
lated during the cell–matrix interaction.
It remains to be seen whether the enhancement in
ICAP-1a phosphorylation during cell attachment involves
Ser/Thr phosphorylation or Tyr phosphorylation. Al-
though Ser/Thr phosphorylation is suspected based on the
amino acid composition of ICAP-1a (21% Ser/Thr) and
the presence of potential protein kinase C and protein ki-
nase A phosphorylation sites, the exact amino acid resi-
dues that are phosphorylated are not known. We have not
been able to demonstrate the immunoreactivity of
ICAP-1a with PY20 anti-phosphotyrosine antibody (data
not shown).
In summary, we present initial characterization of
ICAP-1a, a novel b1 integrin cytoplasmic domain binding
protein. Two observations, (a) the binding of ICAP-1a to
a conserved region of b1 integrin cytoplasmic domain that
previously has been shown to be important for the adhe-
sive function and focal contact localization of integrins,
and (b) the extent of ICAP-1a phosphorylation is regu-
lated during cell–matrix interaction, suggest that ICAP-1a
plays a role during integrin-dependent cell adhesion. b In-
tegrin cytoplasmic domains likely contain overlapping
binding sites for both structural and regulatory proteins
that coordinate cell adhesion and subsequent cytoskeletal
rearrangement. The identification of ICAP-1a together
with the characterization of the sequences on b1 integrin
cytoplasmic domain required for the ICAP-1a binding
should facilitate future studies on how specific integrin-
dependent cellular events are regulated.
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